We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Angle plc (AGL) Ordinary 10p

Sell:14.00p Buy:15.00p 0 Change: 0.50p (3.57%)
Market closed |  Prices as at close on 26 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:14.00p
Buy:15.00p
Change: 0.50p (3.57%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 26 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:14.00p
Buy:15.00p
Change: 0.50p (3.57%)
Market closed |  Prices as at close on 26 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ANGLE plc is a United Kingdom-based liquid biopsy company. The Company is engaged in the development and commercialization of the Parsortix cell separation system, with deployment in liquid biopsy-non-invasive cancer diagnostics. Its platforms include an epitope-independent circulating tumor cell (CTC) harvesting technology and a downstream analysis system for highly multiplexed analysis of nucleic acids and proteins. Its Parsortix PC1 Clinical system captures and harvests circulating CTCs from metastatic breast cancer patients blood for subsequent, user-validated analysis. The Parsortix PC1 Clinical System is a liquid biopsy technology. Its labs in Guildford provide specialist CTC enrichment and analysis services to support translational research studies and pharmaceutical trials. It has developed the Parsortix system, including instruments and one-time use cassettes that can be sold to third-party laboratories for their use in research, pharmaceutical development, or clinical use.

Contact details

Address:
The Surrey Research Park, 10 Nugent Road
GUILDFORD
GU2 7AF
United Kingdom
Telephone:
+44 (01483) 343434
Website:
https://www.angleplc.com/

Important dates

Future events
There are no future events available.
Past events
Trading Announcement 09 November 2023 09/11/23
Interim results 07 September 2023 07/09/23
AGM 28 June 2023 28/06/23

General stock information

EPIC:
AGL
ISIN:
GB0034330679
Market cap:
£37.78 million
Shares in issue:
260.58 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Andrew Newland
    Chief Executive, Executive Director
  • Ian Griffiths
    Finance Director, Company Secretary, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.